James Hambro & Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104M | Buy |
257,327
+22,904
| +10% | +$9.28M | 4.13% | 14 |
|
|
2025
Q1 | $117M | Buy |
234,423
+12,219
| +5% | +$6.08M | 4.87% | 10 |
|
|
2024
Q4 | $116M | Buy |
222,204
+12,751
| +6% | +$6.63M | 4.56% | 11 |
|
|
2024
Q3 | $130M | Buy |
209,453
+11,276
| +6% | +$6.97M | 5.4% | 8 |
|
|
2024
Q2 | $109M | Buy |
198,177
+5,213
| +3% | +$2.88M | 5.09% | 11 |
|
|
2024
Q1 | $112M | Buy |
192,964
+5,071
| +3% | +$2.95M | 5.25% | 7 |
|
|
2023
Q4 | $99.8M | Buy |
187,893
+16,594
| +10% | +$8.82M | 5.31% | 8 |
|
|
2023
Q3 | $86.7M | Buy |
171,299
+13,937
| +9% | +$7.06M | 5.62% | 7 |
|
|
2023
Q2 | $82.1M | Buy |
157,362
+8,193
| +5% | +$4.27M | 5.41% | 6 |
|
|
2023
Q1 | $86M | Buy |
149,169
+2,896
| +2% | +$1.67M | 6.28% | 5 |
|
|
2022
Q4 | $80.6M | Buy |
146,273
+559
| +0.4% | +$308K | 6.15% | 4 |
|
|
2022
Q3 | $74M | Sell |
145,714
-4,263
| -3% | -$2.16M | 6.45% | 4 |
|
|
2022
Q2 | $81.6M | Sell |
149,977
-69
| -0% | -$37.5K | 6.8% | 5 |
|
|
2022
Q1 | $88.7M | Buy |
150,046
+181
| +0.1% | +$107K | 6.3% | 4 |
|
|
2021
Q4 | $100M | Buy |
149,865
+464
| +0.3% | +$310K | 6.79% | 4 |
|
|
2021
Q3 | $85.3M | Buy |
149,401
+7,866
| +6% | +$4.49M | 6.37% | 4 |
|
|
2021
Q2 | $71.4M | Buy |
141,535
+10,286
| +8% | +$5.19M | 5.66% | 6 |
|
|
2021
Q1 | $59.9M | Buy |
131,249
+11,906
| +10% | +$5.44M | 5.54% | 7 |
|
|
2020
Q4 | $55.6M | Buy |
119,343
+9,352
| +9% | +$4.35M | 6.23% | 6 |
|
|
2020
Q3 | $48.5M | Buy |
109,991
+88,792
| +419% | +$39.2M | 6.84% | 6 |
|
|
2020
Q2 | $7.67M | Buy |
21,199
+19,199
| +960% | +$6.95M | 1.19% | 20 |
|
|
2020
Q1 | $567K | Hold |
2,000
| – | – | 0.11% | 33 |
|
|
2019
Q4 | $649K | Hold |
2,000
| – | – | 0.11% | 31 |
|
|
2019
Q3 | $583K | Buy |
+2,000
| New | +$583K | 0.12% | 30 |
|
|
2019
Q1 | $547K | Hold |
2,000
| – | – | 0.16% | 29 |
|
|
2018
Q4 | $447K | Buy |
+2,000
| New | +$447K | 0.18% | 32 |
|